Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion type Assertion NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_head.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion description "[Overexpression of EIF-5A2 was detected in none of the normal ovaries, 7% cystadenomas, 30% borderline tumors, and 53% invasive ovarian carcinomas, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_provenance.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion evidence source_evidence_literature NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_provenance.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion SIO_000772 19054548 NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_provenance.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion wasDerivedFrom befree-20140225 NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_provenance.
- NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_assertion wasGeneratedBy ECO_0000203 NP568355.RAB1Om5Azzj-uNH3Fi3_EDPvXFxsb8-Rs7J9KtE6hv0Xo130_provenance.